Market Tracker

12/12 4:25pm ET

Impax Laboratories Inc (NASDAQ:IPXL)

17.80
Delayed Data
As of 3:59pm ET
 +1.15 / +6.91%
Today’s Change
7.75
Today|||52-Week Range
25.70
+34.34%
Year-to-Date
No recent news for Impax Laboratories Inc.

Today’s Trading

Previous close16.65
Today’s open16.70
Day’s range16.70 - 18.25
Volume1,326
Average volume (3 months)1,568,611
Market cap$1.2B
Data as of 3:59pm ET, 12/12/2017

Growth & Valuation

Earnings growth (last year)-1,327.78%
Earnings growth (this year)-45.48%
Earnings growth (next 5 years)+12.47%
Revenue growth (last year)-4.19%
P/E ratioNM
Price/Sales1.14
Price/Book1.97

Competitors

 Today’s
change
Today’s
% change
AKCAAkcea Therapeutics I...-0.14-0.75%
INVAInnoviva Inc+0.19+1.44%
FWPForward Pharma A/S-0.35-8.75%
PCRXPacira Pharmaceutica...+1.10+2.49%
Data as of 4:00pm ET, 12/12/2017

Financials

Next reporting dateFebruary 27, 2018
EPS forecast (this quarter)$0.13
Annual revenue (last year)$824.4M
Annual profit (last year)-$472.0M
Net profit margin-57.26%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Paul M. Bisaro
Senior Vice President-
Global Operations
Andrew Schaschl
Corporate headquarters
Hayward, California

Forecasts